Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia

Dani Do Hyang Lee, Daniela Cardinale, Ersilia Nigro, Colin R. Butler, Andrew Rutman, Mahmoud R. Fassad, Robert A. Hirst, Dale Moulding, Alexander Agrotis, Elisabeth Forsythe, Daniel Peckham, Evie Robson, Claire M. Smith, Satyanarayana Somavarapu, Philip L. Beales, Stephen L. Hart, Sam M. Janes, Hannah M. Mitchison, Robin Ketteler, Robert E. Hynds, Christopher O'Callaghan

Source: Eur Respir J, 58 (4) 2000455; 10.1183/13993003.00455-2020
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dani Do Hyang Lee, Daniela Cardinale, Ersilia Nigro, Colin R. Butler, Andrew Rutman, Mahmoud R. Fassad, Robert A. Hirst, Dale Moulding, Alexander Agrotis, Elisabeth Forsythe, Daniel Peckham, Evie Robson, Claire M. Smith, Satyanarayana Somavarapu, Philip L. Beales, Stephen L. Hart, Sam M. Janes, Hannah M. Mitchison, Robin Ketteler, Robert E. Hynds, Christopher O'Callaghan. Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia. Eur Respir J, 58 (4) 2000455; 10.1183/13993003.00455-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of a rare respiratory diseases reference centre set-up on primary ciliary dyskinesia care pathway
Source: Eur Respir J, 59 (1) 2102413; 10.1183/13993003.02413-2021
Year: 2022



A high prevalence CCDC103 p.His154Pro mutation causing primary ciliary dyskinesia is associated with normal diagnostic investigations
Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution
Year: 2017

Management of primary ciliary dyskinesia in European children: recommendations and clinical practice
Source: Eur Respir J 2012; 39: 1482-1491
Year: 2012



Access to medicines for rare diseases: beating the drum for primary ciliary dyskinesia
Source: ERJ Open Res, 6 (3) 00377-2020; 10.1183/23120541.00377-2020
Year: 2020



Comparison of diagnostic tools for primary ciliary dyskinesia
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


Implementation of a gene panel for the genetic diagnosis of primary ciliary dyskinesia
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020




SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe
Source: Eur Respir J, 58 (2) 2004548; 10.1183/13993003.04548-2020
Year: 2021



Factors influencing age at diagnosis of primary ciliary dyskinesia in European children
Source: Eur Respir J 2010; 36: 1248-1258
Year: 2010



A pediatric case of CCNO associated congenital mucociliary disease – A novel entity in primary ciliary dyskinesia
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016

A rare genetic mutation in primary ciliary dyskinesia
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017


Diagnosis of primary ciliary dyskinesia: potential options for resource-limited countries
Source: Eur Respir Rev 2017; 26: 160058
Year: 2017



Primary ciliary dyskinesia (PCD): european survey on diagnostic and therapeutic practices
Source: Eur Respir J 2007; 30: Suppl. 51, 403s
Year: 2007

Barriers to new drug development in respiratory disease
Source: Eur Respir J 2016; 47: 356-357
Year: 2016


Barriers to new drug development in respiratory disease
Source: Eur Respir J 2015; 45: 1197-1207
Year: 2015


Cushing‘s syndrome caused by low dose inhaled steroid use for non-existent airways disease. A diagnostic lesson
Source: Eur Respir J 2006; 28: Suppl. 50, 53s
Year: 2006

Are inhaled corticosteroids prescribed rationally in primary ciliary dyskinesia?
Source: Eur Respir J, 51 (3) 1702221; 10.1183/13993003.02221-2017
Year: 2018



Targeted therapy in respiratory disease
Source: Breathe, 17 (4) 210119; 10.1183/20734735.0170-2021
Year: 2021



Accuracy of diagnostic testing in primary ciliary dyskinesia: are we there yet?
Source: Eur Respir J 2016; 47: 699-701
Year: 2016